NIFTY 50▲24,834.85
428.75 (1.76%)
SENSEX▲81,332.72
1292.92 (1.62%)
NIFTY BANK▲51,295.95
407.20 (0.80%)
INDIAN RAILWAY FINANCE CORP▼183.44
-0.12 (-0.07%)
TATA MOTORS▲1,118.30
27.35 (2.51%)
TATA STEEL▲162.55
5.16 (3.28%)
TATA POWER▲444.70
21.35 (5.04%)
SUZLON ENERGY▲61.89
0.42 (0.68%)
RAIL VIKAS NIGAM▼552.35
-23.35 (-4.06%)
INDIAN RENEWABLE ENERGY▼258.03
-3.15 (-1.21%)
VODAFONE IDEA▲15.98
0.80 (5.27%)
RELIANCE INDUSTRIES▲3,018.05
33.25 (1.11%)
YES BANK▲24.97
0.35 (1.42%)
ADANI POWER▲712.65
17.45 (2.51%)
NHPC▲104.62
2.66 (2.61%)
STATE BANK OF INDIA▲862.45
13.95 (1.64%)
HDFC BANK▲1,618.15
1.55 (0.10%)
RELIANCE POWER▲29.77
0.08 (0.27%)
JIO FIN SERVICES LTD▲331.90
2.70 (0.82%)
ZOMATO▲224.62
5.31 (2.42%)
ADANI PORT & SEZ▲1,542.75
55.75 (3.75%)
BHARAT ELECTRONICS▲309.90
8.45 (2.80%)
INDIAN RAILWAY TOURISM CORP▲984.15
15.00 (1.55%)
INDIAN OIL CORP▼176.55
-0.30 (-0.17%)
RATTANINDIA POWER▲16.87
0.06 (0.36%)
MRF▲1,38,870.35
1280.25 (0.93%)
ADANI ENTERPRISES▲3,080.50
107.00 (3.60%)
JAIPRAKASH POWER VENTURES▲19.66
0.83 (4.41%)
  1. home
    apple-store
  2. stocks
    apple-store
  3. stocks list
    apple-store
  4. BAFNA PHARMA
stock logo

BAFNA PHARMA Share Price

BAFNAPH

₹85.00+₹0.62 (0.73%) TodayLast updated on 26 Jul, 2024 | 15:27 IST
₹85.00₹86.60
L
Show Current Price
H

  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹206 Crs

Open

₹86.60

Close

₹84.38

Circuit range

₹88.59 - ₹80.16

Day range

₹85.00 - ₹86.60

Year range

₹73.25 - ₹119.00

Volume

890

Avg. traded

₹85.72

Revenue (12m)

₹152 Crs

BAFNA PHARMABafna Pharmaceuticals Limited is an India-based company, which is engaged in the manufacture of drugs and medicines and selling a reputed brand namely RARICAP. The Company caters to both domestic and international market. It operates in generic pharmaceutical segment. The Company manufactures 336 licensed pharmaceutical formulations and have globally registered 78 of its products. It supplies its products to the United Kingdom, Europe, and Australian markets. The Company's Grantlyon facility has the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. The Company’s subsidiary is Bafna Lifestyles Remedies Limited.

BAFNA PHARMA Key indicators

arrow

52 week high

₹119.00

52 week low

₹73.25

P/E ratio

27.96

P/B ratio

ROE

16.75%

ROCE

16.12%

Dividend yield

--

Debt/Equity ratio

0.31

EPS

4.79

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow

  • Profitability

  • Operational

  • Valuation

Operating profit margin

16.46%

Net profit margin

9.83%

ROE

16.75%

ROA

10.32%

ROCE

16.12%

Learn more

BAFNA PHARMA Shareholder returns

arrow

1 day

-1.09%

1 week

+0.49%

1 month

+13.95%

3 months

-0.58%

1 year

-7.03%

3 years

-44.84%

5 years

+1769.57%

BAFNA PHARMA Share Price history

arrow
DayOpenCloseDay’s change
Thu, Jul 25 2024
₹86.00
₹84.38
-1.88%
Wed, Jul 24 2024
₹83.10
₹86.00
-1.09%
Tue, Jul 23 2024
₹85.00
₹86.95
+2.07%
Mon, Jul 22 2024
₹89.23
₹85.19
+0.22%
Fri, Jul 19 2024
₹84.20
₹85.00
+0.99%
Thu, Jul 18 2024
₹85.58
₹84.17
-1.65%
Tue, Jul 16 2024
₹86.77
₹85.58
-1.37%
Mon, Jul 15 2024
₹91.34
₹86.77
-5.00%

Shareholding info

arrow

Promoters (88.3%)

Mutual Funds (0%)

Retail and other (11.7%)

Foreign institutions-FII (0%)

Other domestic institutions (0%)

Promoters

Learn more

Events

Corporate actions

arrow

  • Rights Issue • 0:0

    Ex date

    expand tab

Learn more

Frequently asked questions